Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer
Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer
Recruiting · NCT04671511 · Registry updated 2025-02-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer | Lymph Node Metastasis, Lymphatic Metastasis, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2025-02-20 | NCT04671511 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jewish General Hospital | 27 |
| Quebec Breast Cancer Foundation | 3 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Hospitalier de l'Université de Montréal | Montreal | Canada | 21 |
| Hôpital Maisonneuve-Rosemont | Montreal | Canada | 4 |
| Jewish General Hospital | Montreal | Canada | 130 |